Product details:
| ISBN13: | 9780323960564 |
| ISBN10: | 0323960561 |
| Binding: | Hardback |
| No. of pages: | 240 pages |
| Size: | 228x152 mm |
| Weight: | 450 g |
| Language: | English |
| 544 |
Category:
Update on Non-Alcoholic Steatohepatitis, An Issue of Clinics in Liver Disease
Series:
The Clinics: Internal Medicine;
27-2;
Publisher: Elsevier
Date of Publication: 12 April 2023
Normal price:
Publisher's listprice:
EUR 86.99
EUR 86.99
Your price:
29 666 (28 254 HUF + 5% VAT )
discount is: 20% (approx 7 417 HUF off)
Discount is valid until: 31 December 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
Click here to subscribe.
Availability:
printed on demand
Can't you provide more accurate information?
Long description:
In this issue, guest editors bring their considerable expertise to this important topic.
-
Contains 20 practice-oriented topics, including metabolic syndrome associated with NASH; genetic markers and comorbidities predisposing to NASH and progressive liver disease; the role of bariatric surgery and endobariatric surgery in NASH; future treatment options and regimens for NAFLD; and more.
-
Provides in-depth clinical reviews on non-alcoholic steatohepatitis, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Table of Contents:
Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers
Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region
Nonalcoholic Fatty Liver Disease in Latin America and Australia
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease
Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease
Special Population: Lean Nonalcoholic Fatty Liver Disease
Special Population: Pediatric Nonalcoholic Fatty Liver Disease
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic fatty liver disease
Research Priorities for Precision Medicine in Nonalcoholic fatty liver disease
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers
Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region
Nonalcoholic Fatty Liver Disease in Latin America and Australia
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease
Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease
Special Population: Lean Nonalcoholic Fatty Liver Disease
Special Population: Pediatric Nonalcoholic Fatty Liver Disease
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic fatty liver disease
Research Priorities for Precision Medicine in Nonalcoholic fatty liver disease